Michael A. Lyon

发表

Dual-specificity phosphatases as targets for antineoplastic agents

P. Wipf, J. Lazo, A. Ducruet, 2002, Nature Reviews Drug Discovery.

Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivo.

S. Gross, J. Blake, K. Davies, 2011, Oncology research.

Discovery of a Pharmacologically Active Antagonist of the Two‐Pore‐Domain Potassium Channel K2P9.1 (TASK‐3)

Steven V. Fox, S. Doran, J. Renger, 2012, ChemMedChem.

Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease.

Bin Wang, G. Vigers, S. Seiwert, 2014, Journal of medicinal chemistry.

Glyoxylic acid and MP-glyoxylate: efficient formaldehyde equivalents in the 3-CC of 2-aminoazines, aldehydes, and isonitriles.

Michael A. Lyon, T. Kercher, 2004, Organic letters.

Small Molecule Modulators of Endogenous and Co-chaperone-stimulated Hsp70 ATPase Activity*

P. Wipf, J. Brodsky, B. Day, 2004, Journal of Biological Chemistry.

Synthesis and structure verification of an analogue of kuanoniamine A

David J. Williams, Michael A. Lyon, S. Lawrence, 1999 .

Synthesis and Isolation of Some Benzo[c]tellurophenes

Michael A. Lyon, M. Cava, M. V. Lakshmikantham, 2000 .

Reactions of some N-(2,5-dimethoxyaryl)thiobenzamides: en route to an analogue of kuanoniamine A

Michael A. Lyon, Y. Jackson, N. Townsend, 2000 .

FUNCTIONALIZATION OF 3,4-ETHYLENEDIOXYTHIOPHENE

Michael A. Lyon, M. Cava, A. Mohanakrishnan, 1999 .

Discovery of a Pharmacologically Active Antagonist of the Two‐Pore‐Domain Potassium Channel K2P9.1 (TASK‐3)

Steven V. Fox, S. Doran, J. Renger, 2012, ChemMedChem.

Catalytic asymmetric aziridination of aryl imines

P. Wipf, Michael A. Lyon, 2007 .